Volume 14, Number 6—June 2008
Validation of Syndromic Surveillance for Respiratory Pathogen Activity
|Syndrome data||RSV||Influenza A||Influenza B||S. pneumoniae (residual)||RV||PIV||Adenovirus||Enterovirus||Mycoplasma pneumoniae||Bordetella pertussis|
*S. pneumoniae, Streptococcus pneumoniae; RSV, respiratory syncytial virus; RV, rhinovirus; PIV, parainfluenza virus; GP, general practice; –, pathogen not included in model.
†The lag time (in weeks) is indicated, that showed optimal fit between syndrome time-series and lagged pathogen counts included in the linear regression model; e.g., according to the model, the trend in hospitalizations precedes the influenza A laboratory counts by 2 weeks.
- Page created: July 09, 2010
- Page last updated: July 09, 2010
- Page last reviewed: July 09, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)